Financial report interval: 2025.12.31 - 2026.03.31
Preview: ZHIFEI-BIOL(300122) predict that the Revenue is 2.15 B (-9.45%), Miss estimate;the EBIT is -442 M (-32.84%), Miss estimate;the EPS is -0.162 (-27.22%), Miss estimate.